Evidence map›Paper›PMID 33534034›Full record

ArticleChild psychiatry and human development2022

Serum Galanin in Children with Autism Spectrum Disorder.

Khaled Saad, Ahmed A Abdel-Rahman, Abdulrahman A Al-Atram, Alam-Eldin M Abdallah, Amira Elhoufey, Eman M Nagiub Abdelsalam, Dalia A Nigm, Ola Elshora, Ahmad Roshdy Ahmad, Mohamed M El-Tellawy and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in Child psychiatry and human development, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Khaled SaadDepartment of Pediatrics, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt. ksaad8@yahoo.com.ORCID 0000-0002-8473-6116
Ahmed A Abdel-RahmanDepartment of Neuropsychiatry, Faculty of Medicine, Assiut University, Assiut, Egypt.
Abdulrahman A Al-AtramDepartment of Psychiatry, College of Medicine, Majmaah University, Al Majmaah, Kingdom of Saudi Arabia.
Alam-Eldin M AbdallahDepartment of Pediatrics, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt.
Amira ElhoufeyDepartment of Community Health Nursing, Faculty of Nursing, Assiut University, Assiut, Egypt.
Eman M Nagiub AbdelsalamClinical Pathology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Dalia A NigmClinical Pathology Department, Faculty of Medicine, Assiut University, Assiut, Egypt.
Ola ElshoraClinical Pathology Department, Faculty of Medicine, Tanta University, Tanta, Egypt.
Ahmad Roshdy AhmadDepartment of Pediatrics, College of Medicine, Jouf University, Sakakah, Kingdom of Saudi Arabia.
Mohamed M El-TellawyDepartment of Pediatrics, College of Medicine, Jouf University, Sakakah, Kingdom of Saudi Arabia.
Khaled Hashim MahmoudDepartment of Pediatrics, Faculty of Medicine, Assiut University, Assiut, 71516, Egypt.
Assiut University · EGJouf University · SAMajmaah University · SATanta University · EG

Funding

Majmaah University 220-2018
6 · The paper itself

Abstract

Recent studies have attempted to measure several biomarkers to understand the complex interactions of the anatomic systems that may be involved in autism spectrum disorder (ASD). In CNS, galanin takes part in a variety of pathological and physiological processes. Prior research has indicated it is involved in several neuropsychiatric disorders and has a role in inhibiting the neuronal firing and release of serotonin, norepinephrine, and acetylcholine. To date, serum galanin levels have not been investigated in the context of ASD. This study aimed, therefore, to compare the serum galanin levels of children with ASD and healthy controls and to reveal any association between galanin level and the severity of ASD, as well as other psychological and demographic parameters. Serum galanin levels were measured by radioimmunoassay in 116 children with ASD and 98 healthy children. We observed significantly increased serum concentrations of galanin in children with ASD relative to healthy children. Moreover, children with severe ASD had significantly higher galanin levels than those with less severe disease. We also confirmed significant positive correlations between galanin and psychiatric parameters in children with ASD. For the first time, we suggest a possible correlation between serum galanin and the degree of ASD severity. Increased galanin levels may play a role in the pathogenesis of ASD.

Indexed as

Autism Spectrum DisorderBiomarkersChildGalaninHumansBiomarkersGalaninAutismCARSChildrenGalanin

Identifiers

PMID33534034
OpenAlexW3127478576

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.